Matthew Hershenhorn

Stock Analyst at Oppenheimer

(3.17)

# 2,437

Out of 4,361 analysts

Total ratings

100%

Success rate

81.5%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Matthew Hershenhorn

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ACAD ACADIA Pharmaceuticals	Maintained: Hold	$23	$20.89	+10.10%	6	May 22, 2026
	AXSM Axsome Therapeutics	Rated: Buy	$183 → $250	$222.16	+12.53%	6	May 1, 2026

ACADIA Pharmaceuticals

May 22, 2026

Maintained: Hold

Price Target: $23

Current: $20.89

Upside: +10.10%

Axsome Therapeutics

May 1, 2026

Rated: Buy

Price Target: $183 → $250

Current: $222.16

Upside: +12.53%